Email Updates

Search form

You are here

Webinar & Meeting Reports

  • October 14, 2014
    A New-York based panel discussion featured doctors, PrEP users, activists, focusing on what PrEP means for women.
  • October 8, 2014

    In Melbourne, UNAIDS launched a new initiative known as “90-90-90”, which lays out new targets for testing, treatment and virologic suppression. Where did these targets come from, what do they mean—and where does prevention fit in? Chris Collins, Chief of the Community Mobilization Division at UNAIDS addressed these questions and more.

  • October 2, 2014 to October 5, 2014

    USCA is the largest AIDS-related gathering in the US, bringing together thousands of workers from all fronts of the HIV/AIDS epidemic to build national support networks and exchange the latest information. In 2014, USCA “will continue to highlight how the Affordable Care Act can help us draw even closer to ending the epidemic, while focusing on the challenges we still have to overcome to achieve this vision.”

  • October 1, 2014

    AIDS 2014 featured analyses of data on the potential relationship between hormonal contraceptives and risk of HIV infection. Researchers Charles Morrison (FHI 360) and Kristin Wall (Emory University), and Mary Lyn Gaffield from the WHO discussed the newest findings and guidance.

  • September 24, 2014

    Get details on the iPrEx OLE study from principal investigator Robert Grant, who presented the data at AIDS 2014. The first open-label PrEP study to publish results, these data from iPrEx OLE begin to answer a number of questions on PrEP use in the “real world”.

  • September 23, 2014
    Slides, audio and a Flash animation are available.
  • September 17, 2014

    AIDS 2014 brought more updates on voluntary medical male circumcision (VMMC) including new data on risk behaviors in circumcised men, the impact of cash transfers as part of VMMC programming and more. Kenyan researcher and implementer Kawango Agot reviewed the latest findings.

  • September 3, 2014

    The field of cure research is evolving and expanding, with various proposed trials that require informed engagement from many stakeholders. Plenary speaker, Jintanat Ananworanich, provides an update, discusses research, and answers questions.

  • August 14, 2014

    The Canadian HIV Vaccine Initiative (CHVI) Research and Development Alliance Coordinating Office (ACO) invites you to join us for a webinar entitled “Do we need a new paradigm for HIV vaccine development?” with Dr. José Esparza who will give participants a greater understanding of some of the lessons learned after 30 years of HIV vaccine development.

  • July 20, 2014 to July 25, 2014

    The International AIDS Conference, or AIDS 2014, is a biennial gathering for those working in the field of HIV, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic.